v1
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
Identifier:nobleid.org/w1/20260515/B2FEC5F4
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/B2FEC5F4)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims